Información de Indivior PLC, dividendo de Indivior PLC, actividades de los accionistas y más

Más Datos de Indivior PLC Compañía

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Información de Indivior PLC



Símbolo de cotizaciónINDV

Nombre de la empresaIndivior PLC

Fecha de salida a bolsaDec 24, 2014

Director ejecutivoCiaffoni (Joseph J)

Número de empleados1030

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 24

Dirección234 Bath Road

CiudadSLOUGH

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited Kingdom

Código postalSL1 4EE

Teléfono448043791090

Sitio Webhttps://www.indivior.com/en

Símbolo de cotizaciónINDV

Fecha de salida a bolsaDec 24, 2014

Director ejecutivoCiaffoni (Joseph J)

Ejecutivos de Indivior PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Christian Heidbreder

Chief Scientific Officer

157.14K

+157140.00%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+4329.00%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.78K

+775.00%

Ms. Juliet Thompson

Senior Non-Executive Independent Director

9.63K

+5775.00%

Dr. Keith Humphreys

Non-Executive Independent Director

3.15K

-725.00%

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

760.00

--

Ms. Kathryn Barbara Hudson

Company Secretary

--

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

--

Mr. Mark P. Stejbach

Non-Executive Independent Director

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Christian Heidbreder

Chief Scientific Officer

157.14K

+157140.00%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+4329.00%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.78K

+775.00%

Ms. Juliet Thompson

Senior Non-Executive Independent Director

9.63K

+5775.00%

Dr. Keith Humphreys

Non-Executive Independent Director

3.15K

-725.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

La empresa aún no ha revelado los datos relevantes.

Por regiónUSD

Nombre

Ganancia

Proporción

United States

267.00M

85.03%

Rest of World

47.00M

14.97%

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: jue., 4 de dic

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.24%

Oaktree Capital Management, L.P.

5.69%

Madison Avenue Partners LP

5.18%

Goldman Sachs & Company, Inc.

5.13%

Two Seas Capital LP

4.98%

Otro

72.78%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.24%

Oaktree Capital Management, L.P.

5.69%

Madison Avenue Partners LP

5.18%

Goldman Sachs & Company, Inc.

5.13%

Two Seas Capital LP

4.98%

Otro

72.78%

Tipos de accionistas

Accionistas

Proporción

Hedge Fund

33.03%

Investment Advisor/Hedge Fund

26.95%

Investment Advisor

13.84%

Research Firm

11.85%

Individual Investor

3.74%

Pension Fund

0.64%

Bank and Trust

0.31%

Family Office

0.27%

Otro

9.37%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1

2.06K

0.00%

--

2025Q3

372

118.02M

94.53%

+2.51M

2025Q2

354

123.13M

98.21%

+4.02M

2025Q1

380

119.99M

96.15%

-1.70M

2024Q4

382

116.83M

93.64%

-10.43M

2024Q3

369

117.73M

91.72%

-15.91M

2024Q2

352

119.29M

90.10%

-8.99M

2024Q1

341

129.79M

96.57%

+3.79M

2023Q4

322

124.43M

92.28%

+2.93M

2023Q3

321

114.40M

84.40%

+17.06M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

7.79M

6.24%

+2.75M

+54.61%

Sep 30, 2025

Oaktree Capital Management, L.P.

7.11M

5.69%

-1.64M

-18.71%

Dec 24, 2025

Madison Avenue Partners LP

6.46M

5.18%

-1.46M

-18.41%

Sep 30, 2025

Goldman Sachs & Company, Inc.

6.41M

5.13%

+5.95M

+1302.98%

Sep 30, 2025

Two Seas Capital LP

6.21M

4.98%

-3.04M

-32.87%

Dec 23, 2025

Morgan Stanley & Co. LLC

5.58M

4.47%

+5.04M

+934.24%

Sep 30, 2025

Deerfield Management Company, L.P.

4.61M

3.7%

-2.37M

-33.95%

Nov 10, 2025

Newtyn Management, LLC

4.20M

3.36%

+1.59M

+61.10%

Sep 30, 2025

The Vanguard Group, Inc.

3.44M

2.76%

-2.18M

-38.82%

Sep 30, 2025

Sirovich (Matthew I.)

3.42M

2.74%

+249.62K

+7.87%

Sep 30, 2024

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Lattice Hartford Multifactor Small Cap ETF

1.11%

ProShares Ultra Nasdaq Biotechnology

0.51%

Federated Hermes MDT Small Cap Core ETF

0.47%

Janus Henderson Small Cap Growth Alpha ETF

0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

0.38%

Invesco Nasdaq Biotechnology ETF

0.36%

Franklin US Small Cap Multifactor Index ETF

0.32%

First Trust Active Factor Small Cap ETF

0.31%

Vanguard US Multifactor ETF

0.27%

Pacer US Small Cap Cash Cows ETF

0.26%

Lattice Hartford Multifactor Small Cap ETF

Proporción1.11%

ProShares Ultra Nasdaq Biotechnology

Proporción0.51%

Federated Hermes MDT Small Cap Core ETF

Proporción0.47%

Janus Henderson Small Cap Growth Alpha ETF

Proporción0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

Proporción0.38%

Invesco Nasdaq Biotechnology ETF

Proporción0.36%

Franklin US Small Cap Multifactor Index ETF

Proporción0.32%

First Trust Active Factor Small Cap ETF

Proporción0.31%

Vanguard US Multifactor ETF

Proporción0.27%

Pacer US Small Cap Cash Cows ETF

Proporción0.26%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos